A pharmaceutical company proposes to make pseudoephedrine, used for colds and flu, more accessible by removing it from pharmacy counters. Currently, this medication is subject to restrictions, requiring a request to the pharmacist. Reckitt Benckiser argues that this measure would improve access to an effective decongestant while easing the workload of pharmacists. The request will be reviewed soon by the regulatory authority.